- Editor's PickSeana Smith•yesterday
Yahoo Finance is tracking the stocks you’re following, based on your Yahoo Finance ticker searches.
- Market Realist•2 hours ago
AstraZeneca (AZN) has four drugs that recently received approvals from regulatory authorities. Four other drugs recently received regulatory designations.
- Market Realist•3 hours ago
AstraZeneca is reducing its selling, general, and administrative expenses for better profitability. Its R&D costs will be in line with 2015.
AstraZeneca PLC (AZN)
NYSE - NYSE Real Time Price. Currency in USD
|Bid||33.49 x 1700|
|Ask||33.50 x 2000|
|Day's Range||33.25 - 33.56|
|52wk Range||26.97 - 35.04|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||38.27|
|Avg Vol (3m)||6,165,301|
|Dividend & Yield||0.90 (2.66%)|